Morgan Stanley Penumbra Inc Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

A detailed history of Morgan Stanley transactions in Penumbra Inc stock. As of the latest transaction made, Morgan Stanley holds 438,710 shares of PEN stock, worth $119 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

438,710

Previous 442,898 0.95%

Holding current value

$119 Million

Previous $86 Million 21.15%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$190.97 - $253.66 $799,782 - $1.06 Million	-4,188 Reduced 0.95%	438,710 $104 Million
Q3 2024 Nov 14, 2024	BUY	$163.64 - $210.12 $16.8 Million - $21.6 Million	102,836 Added 30.24%	442,898 $86 Million
Q2 2024 Oct 17, 2024	SELL	$172.27 - $223.95 $8.44 Million - $11 Million	-48,994 Reduced 12.59%	340,062 $61.2 Million
Q2 2024 Aug 14, 2024	SELL	$172.27 - $223.95 $8.44 Million - $11 Million	-48,994 Reduced 12.59%	340,062 $61.2 Million
Q1 2024 Oct 17, 2024	BUY	$220.09 - $273.15 $10.8 Million - $13.4 Million	48,994 Added 14.41%	389,056 $86.8 Million
Q1 2024 Aug 16, 2024	BUY	$220.09 - $273.15 $5.29 Million - $6.56 Million	24,032 Added 6.58%	389,056 $86.8 Million
Q1 2024 May 15, 2024	BUY	$220.09 - $273.15 $5.29 Million - $6.56 Million	24,032 Added 6.58%	389,056 $86.8 Million
Q4 2023 Aug 16, 2024	BUY	$181.44 - $260.22 $4.53 Million - $6.5 Million	24,962 Added 7.34%	365,024 $91.8 Million
Q4 2023 Feb 13, 2024	BUY	$181.44 - $260.22 $2.06 Million - $2.95 Million	11,339 Added 3.21%	365,024 $91.8 Million
Q3 2023 Nov 15, 2023	BUY	$240.69 - $338.77 $5.82 Million - $8.2 Million	24,196 Added 7.34%	353,685 $85.6 Million
Q2 2023 Aug 14, 2023	SELL	$271.54 - $344.06 $16.4 Million - $20.8 Million	-60,476 Reduced 15.51%	329,489 $113 Million
Q1 2023 May 15, 2023	BUY	$220.43 - $278.69 $15.2 Million - $19.3 Million	69,089 Added 21.53%	389,965 $109 Million
Q4 2022 Feb 14, 2023	BUY	$151.88 - $228.5 $37.4 Million - $56.3 Million	246,451 Added 331.14%	320,876 $71.3 Million
Q3 2022 Nov 14, 2022	BUY	$120.36 - $205.88 $268,523 - $459,318	2,231 Added 3.09%	74,425 $14.1 Million
Q2 2022 Oct 27, 2022	BUY	$116.09 - $227.33 $360,807 - $706,541	3,108 Added 4.5%	72,194 $8.99 Million
Q2 2022 Aug 15, 2022	BUY	$116.09 - $227.33 $360,807 - $706,541	3,108 Added 4.5%	72,194 $8.99 Million
Q1 2022 Oct 27, 2022	SELL	$187.51 - $283.98 $582,781 - $882,609	-3,108 Reduced 4.31%	69,086 $15.3 Million
Q1 2022 May 13, 2022	SELL	$187.51 - $283.98 $4.33 Million - $6.56 Million	-23,097 Reduced 25.06%	69,086 $15.3 Million
Q4 2021 Feb 14, 2022	SELL	$238.08 - $288.0 $7.86 Million - $9.5 Million	-32,995 Reduced 26.36%	92,183 $26.5 Million
Q3 2021 Nov 15, 2021	BUY	$250.72 - $291.24 $31.4 Million - $36.5 Million	125,178 New	125,178 $33.4 Million

Others Institutions Holding PEN

# of Institutions

412

Shares Held

29.3M

Call Options Held

254K

Put Options Held

43.3K

View Full List

About Penumbra Inc

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $10.2B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

More about PEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account